China-based intraoperative nerve monitoring technology developer Beijing Huashen Shengdian Medical Technology Co., Ltd has reportedly secured an undisclosed amount of angel funding. The round was led by Tus Star, with participation from Wuxi Kelin Venture Capital Partnership. The proceeds will be directed towards accelerating the research and development of pelvic surgery monitor equipment and expanding the R&D team.
Huashen Shengdian’s Innovative Pelvic Surgery Monitor
Huashen Shengdian’s pelvic surgery monitor represents a significant advancement in the field. It is the first integrated collection of multiple composite indicators that boasts sensitivity and accuracy. The monitor is designed to actively explore nerve distribution and passively monitor nerve activity, thereby maximizing the protection of patients’ nerves and preventing postoperative disability. Its innovative physical structure design enables non-invasive and painless monitoring, significantly reducing the complexity of product use and the time required for operation preparation.
Market Outlook for Intraoperative Nerve Monitoring
According to an information consulting company, the global intraoperative nerve monitoring market was valued at RMB 3.042 billion (USD 442 million) in 2021. This market is projected to grow to RMB 4.105 billion (USD 597 million) by 2027, reflecting a compound annual growth rate (CAGR) of 5.19%. This growth trajectory underscores the potential for Huashen Shengdian’s technology to make a substantial impact in the medical technology sector.-Fineline Info & Tech
